EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+7.55%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$350M
AUM Growth
+$350M
(+3.6%)
Cap. Flow
-$4.54M
Cap. Flow
% of AUM
-1.3%
Top 10 Holdings %
Top 10 Hldgs %
61.71%
Holding
69
New
18
Increased
19
Reduced
16
Closed
8
Top Buys
| 1 |
The Ensign Group
ENSG
|
$8.31M |
| 2 |
Illumina
ILMN
|
$6.73M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$6.32M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$6.04M |
| 5 |
Centene
CNC
|
$3.99M |
Top Sells
| 1 |
NUVA
NuVasive, Inc.
NUVA
|
$14M |
| 2 |
Sarepta Therapeutics
SRPT
|
$10.2M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$9.74M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$7.81M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$5.45M |
Sector Composition
| 1 | Healthcare | 76.2% |
| 2 | Industrials | 9.7% |
| 3 | Financials | 4.4% |
| 4 | Real Estate | 1.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSKA
26
DELISTED
Heska Corp
HSKA
| $2.97M | 0.83% |
34,924
+28,244
| +423% | +$2.41M |
|
27
Apellis Pharmaceuticals
APLS
$3.51B
| $2.97M | 0.83% |
117,309
+12,960
| +12% | +$328K |
|
|
MYOK
28
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.84M | 0.8% |
56,652
+21,600
| +62% | +$1.08M |
|
29
Elevance Health
ELV
$72.4B
| $2.82M | 0.79% |
+10,000
| New | +$2.82M |
|
30
Humana
HUM
$37.5B
| $2.66M | 0.74% |
+10,000
| New | +$2.66M |
|
|
31
Sarepta Therapeutics
SRPT
$1.98B
| $2.52M | 0.7% |
16,554
-67,020
| -80% | -$10.2M |
|
|
GHDX
32
DELISTED
Genomic Health, Inc.
GHDX
| $2.23M | 0.63% |
+38,403
| New | +$2.23M |
|
33
Xenon Pharmaceuticals
XENE
$2.99B
| $2.21M | 0.62% |
224,340
| – | – |
|
34
PTC Therapeutics
PTCT
$4.41B
| $2.19M | 0.61% |
48,600
-52,000
| -52% | -$2.34M |
|
|
MDCO
35
DELISTED
Medicines Co
MDCO
| $2.09M | 0.58% |
57,200
-19,000
| -25% | -$693K |
|
36
Collegium Pharmaceutical
COLL
$1.25B
| $1.85M | 0.52% |
+141,000
| New | +$1.85M |
|
|
BDSI
37
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.66M | 0.46% |
+356,274
| New | +$1.66M |
|
|
TLGT
38
DELISTED
Teligent, Inc
TLGT
| $1.63M | 0.46% |
2,584,883
+10,000
| +0.4% | +$6.3K |
|
39
Sabra Healthcare REIT
SBRA
$4.56B
| $1.55M | 0.43% |
+78,600
| New | +$1.55M |
|
40
Omega Healthcare
OHI
$12.5B
| $1.52M | 0.43% |
+41,400
| New | +$1.52M |
|
|
LTC
41
LTC Properties
LTC
$1.67B
| $1.51M | 0.42% |
+33,027
| New | +$1.51M |
|
42
CareTrust REIT
CTRE
$7.53B
| $1.5M | 0.42% |
62,464
+21,200
| +51% | +$509K |
|
43
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.3M | 0.36% |
342,460
-70,416
| -17% | -$267K |
|
|
IVC
44
DELISTED
Invacare Corporation
IVC
| $1.09M | 0.31% |
210,283
+131,202
| +166% | +$681K |
|
|
AFMD
45
DELISTED
Affimed
AFMD
| $925K | 0.26% |
322,171
| – | – |
|
|
PRVB
46
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $891K | 0.25% |
+73,661
| New | +$891K |
|
|
OPTN
47
DELISTED
OptiNose
OPTN
| $744K | 0.21% |
+105,106
| New | +$744K |
|
|
EIGR
48
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $739K | 0.21% |
69,708
| – | – |
|
|
AKRX
49
DELISTED
Akorn, Inc.
AKRX
| $678K | 0.19% |
+131,640
| New | +$678K |
|
|
DRNA
50
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $647K | 0.18% |
41,074
| – | – |
|